SCHEMBL29679686

SCHEMBL29679686

COc1ccc(NC(=O)C(F)(F)F)c(Br)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.55
TSHR P16473 1/20 0.55
POLB P06746 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
ALDH1A1 P00352 4/20 0.49
GAA P10253 2/20 0.49
THRB P10828 1/20 0.49
KDM4E B2RXH2 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
F10 P00742 1/20 0.45
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
NQO2 P16083 1/20 0.45
MTNR1A P48039 1/20 0.45
MTNR1B P49286 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5788197 1.00 NPSR1 (0.55) NPSR1TSHRPOLBMEN1KMT2A
SCHEMBL8320012 0.92 NPSR1 (0.48) NPSR1TSHRPOLBMEN1KMT2A
SCHEMBL8320016 0.88 NPSR1 (0.45) NPSR1TSHRPOLBMEN1KMT2A
SCHEMBL27430704 0.84 TSHR (0.55) NPSR1TSHRMEN1KMT2AALDH1A1
SCHEMBL2552734 0.84 TSHR (0.74) NPSR1TSHRMEN1KMT2AALDH1A1
SCHEMBL29785065 0.84 TSHR (0.74) NPSR1TSHRMEN1KMT2AALDH1A1
SCHEMBL7308049 0.81 TSHR (0.51) NPSR1TSHRMEN1KMT2AALDH1A1
SCHEMBL14409902 0.81 GAA (0.51) NPSR1TSHRMEN1KMT2AGAA
SCHEMBL27010697 0.81 RAB9A (0.55) POLBMEN1KMT2AALDH1A1GAA
SCHEMBL15072456 0.80 NPC1 (0.47) POLBMEN1KMT2AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022114808-A1 NEW SMALL-MOLECULE COMPOUND FOR CONTROLLING ENDOSOMAL TOLL-LIKE RECEPTOR AND THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES USING SAME 에스앤케이테라퓨틱스 2022-06-02 WO disclosed